MedVi vs RxActivate: Pricing, Process and Medication Options
Quick verdict: MedVi is clearer on price and offers a $179 first-month promotional compounded semaglutide program with no clinic visits and 24/7 certified medical support, while RxActivate requires an eligibility questionnaire and gates pricing and plan details behind contact-information before revealing costs. This makes MedVi the more transparent option; RxActivate is for users who prefer clinician-matched plans and will complete the intake flow.
See MedVi pricing and plan details
MedVi vs RxActivate: Pricing transparency and how you learn cost
MedVi publishes a winter promotional starting price of $179 for the first month including fast, free shipping, and notes a standalone month at $299 with a three-month plan at $649. RxActivate does not display pricing or billing terms before the contact-information gate; plan and price details are revealed only after completing the eligibility flow and providing name, email and phone number. The difference is direct: MedVi gives an explicit promotional starting price, RxActivate requires intake to see pricing.
Start RxActivate eligibility quiz
Intake process and clinician review
MedVi uses a simple online intake with no clinic visits and an online clinician review by OpenLoop Health clinicians who determine prescription eligibility. RxActivate uses a two-minute eligibility questionnaire that asks for goals, medical history and safety screening and then requires contact information before revealing plan options. Both require clinician review; the user experience differs because MedVi emphasizes a full online program without in-person visits while RxActivate emphasizes clinician-matching after the gated intake.
Medication types, compounding and regulatory notes
MedVi explicitly offers clinically dosed compounded semaglutide and notes compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. MedVi states its compounded semaglutide uses the same active ingredient as Ozempic and Wegovy and that prescriptions are at the discretion of medical providers. RxActivate notes clinician-matched GLP-1 plans and that when compounded medications are offered they are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. MedVi calls out semaglutide only and no tirzepatide option, while RxActivate does not display specific medication options before intake.
Support, outcomes and evidence claims
MedVi advertises 24/7 support from certified medical professionals and references self-reported patient data and typical reported weight loss ranges with qualifiers and program adherence caveats. RxActivate does not publish outcome details in the captured evidence; it focuses on eligibility flow and clinician matching. Where MedVi supplies program features and patient-reported data with explicit qualifiers, RxActivate supplies enrollment flow and availability notes without outcome claims in the captured material.
Five quick comparison criteria
| Criteria | MedVi | RxActivate |
|---|---|---|
| Starting price | $179 first month promotional, ongoing rates disclosed | Unverified; gated behind eligibility and contact info |
| Pricing visibility | Published promotional price and program rates | No price shown before inputting contact information |
| Intake process | Simple online intake, no clinic visits | Two-minute eligibility questionnaire, clinician-matched plan |
| Medication type | Clinically dosed compounded semaglutide only | Clinician-matched GLP-1 plans; specifics gated until intake |
| Support and claims | 24/7 certified medical support; self-reported patient data with qualifiers | State and medical-safety screening; outcome claims not captured |
How each provider frames risks and regulatory status
MedVi explicitly states compounded medications are not FDA-approved and encourages discussion with providers about risks and benefits. RxActivate also notes that compounded medications, when offered, are not FDA-approved and that branded and compounded products are not interchangeable. Both preserve the regulatory qualifier about compounded products not being FDA-reviewed.
Explore MedVi program details and support
Choosing between MedVi and RxActivate
Use the primary keyword MedVi vs RxActivate when deciding based on what matters to you. Choose MedVi if you value published promotional pricing, an online no-clinic process, compounded semaglutide from $179 first month and 24/7 certified support. Choose RxActivate if you prefer clinician-matched plans and are willing to complete the eligibility questionnaire and provide contact details to learn actual pricing, plan options and state availability.